Hybridon

Hybridon, Inc (Amex: HBY) was a biotechnology company based in Cambridge, Massachusetts, specializing in the discovery and development of novel therapeutics and diagnostics using synthetic DNA, that merged with Idera Pharmaceuticals in 2004.

Notable investors

According to a U.S. Securities and Exchange Commission filing of May 4, 1999[1] Hybridon had investors with 5% or more ownership including:

References

External links


This article is issued from Wikipedia - version of the 5/29/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.